NLRP3 and systemic lupus erythematosus: Inhibition of caspase-1 or NLRP3-mediated inflammasome signaling in murine models has demonstrated that inflammasome pathways contribute to SLE pathogenesis by promoting autoantibody production, endothelial dysfunction, and nephritis (10–14).